Strategic Growth Recently expanding to a larger facility in Salem NH in Q1 2027 presents an opportunity to upsell CRO services and capacity for expanding client work, especially for high-demand in vivo immunology studies and larger preclinical programs.

Deep Immunology Focus Specialization in rodent in vivo immunology and autoimmune disease models (EAE, CIA, colitis, SLE) positions Hooke as a go-to partner for clients seeking rigorous preclinical immune profiling, enabling cross-sell into advanced analytics like RNA-seq, scRNA-seq and cytokine analysis.

Offset Competitive Gap Hooke serves major pharma and biotech clients with a reputation for quality and scientific rigor; sales conversations can highlight efficiency, reduced red tape, and study design expertise to win work from larger CROs that may underdeliver on immunology projects.

Full Service Capabilities Existing portfolio includes histology, multiplex immunofluorescence, flow cytometry, bioinformatics, and sequencing services, enabling bundled offerings or tiered service packages to increase average contract value with current customers.

No Layoffs, Stability Stable workforce history and founder-led control can be leveraged to reassure potential clients about continuity and dedicated client attention, supporting long-term collaborations and larger multi-year studies.